| 000 | 01361 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513094204.0 | ||
| 264 | 0 | _c19961024 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0195-6108 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatterson, J | |
| 245 | 0 | 0 |
_aA spurious description of hyperfixation of HMPAO. _h[electronic resource] |
| 260 |
_bAJNR. American journal of neuroradiology _cMay 1996 |
||
| 300 |
_a998-9; author reply 999-1000 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aCerebral Infarction _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xdiagnostic imaging |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperemia _xdiagnostic imaging |
| 650 | 0 | 4 |
_aIntracranial Embolism and Thrombosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOrganotechnetium Compounds _xpharmacokinetics |
| 650 | 0 | 4 |
_aOximes _xpharmacokinetics |
| 650 | 0 | 4 |
_aPlasminogen Activators _xtherapeutic use |
| 650 | 0 | 4 | _aReperfusion |
| 650 | 0 | 4 | _aTechnetium Tc 99m Exametazime |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 700 | 1 | _aWyper, D J | |
| 700 | 1 | _aHadley, D M | |
| 773 | 0 |
_tAJNR. American journal of neuroradiology _gvol. 17 _gno. 5 _gp. 998-9; author reply 999-1000 |
|
| 999 |
_c8731050 _d8731050 |
||